Will AstraZeneca’s 3 types of antibody be transferred to ‘Alvogen’?
AstraZeneca’s 3 types of antibody are expected to be transferred to Alvogen.
According to the industry concerned on the 26th, the two companies are discussing license transfers of 3 current breast cancer therapies, such as ‘Nolvadex(tamoxifen),’ ‘Arimidex(anastrozole)’ and ‘Faslodex(fulvestrant)...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
